Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Botulinum Toxin Type A

Brand: All brands within licensed indications only
NICE TA: CG171
Indication: Detrusor overactivity - urology (NICE CG171)
Disease category: Central nervous system
Commissioning responsibility: CCG
PbR excluded: Yes

Background

NICE has recommended in the clinical guideline for urinary incontinence that Botulinum toxin A can be used to treat idiopathic detrusor overactivity in those willing and able to self-catheterise. Please note: NHS England is the responsible commissioner for treatment of incontinence associated with neurological conditions such as paraplegia or multiple sclerosis.

Recommendation

LMMG recommendation: Red
Click here to find the definitions for the colour classifications

Reason for decision:  Specialist medicine

Supporting documents:

NICE CG171 - Urinary incontinence in women 

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG

Red

Red